PubMed

Use of genotypic resistance testing to guide hiv therapy: clinical impact and cost-effectiveness.

Weinstein MC, Goldie SJ, Losina E, Cohen CJ, Baxter JD, Zhang H, Kimmel AD, Freedberg KA.

Ann Intern Med. 2001 Mar 20;134(6):440-50.PMID: 11255519 [PubMed - indexed for MEDLINE]Related articlesFree article

The cost effectiveness of combination antiretroviral therapy for HIV disease.

Freedberg KA, Losina E, Weinstein MC, Paltiel AD, Cohen CJ, Seage GR, Craven DE, Zhang H, Kimmel AD, Goldie SJ.

N Engl J Med. 2001 Mar 15;344(11):824-31.PMID: 11248160 [PubMed - indexed for MEDLINE]Related articlesFree article

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.PMID: 11813503 [PubMed - indexed for MEDLINE]Related articles

Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis.

Sax PE, Islam R, Walensky RP, Losina E, Weinstein MC, Goldie SJ, Sadownik SN, Freedberg KA.

Clin Infect Dis. 2005 Nov 1;41(9):1316-23. Epub 2005 Sep 23.PMID: 16206108 [PubMed - indexed for MEDLINE]Related articles

Optimal frequency of CD4 cell count and HIV RNA monitoring prior to initiation of antiretroviral therapy in HIV-infected patients.

Kimmel AD, Goldie SJ, Walensky RP, Losina E, Weinstein MC, Paltiel AD, Zhang H, Freedberg KA; Cost-Effectiveness of Preventing AIDS Complications Investigators.

Antivir Ther. 2005;10(1):41-52.PMID: 15751762 [PubMed - indexed for MEDLINE]Related articles

The long-term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model-based approach.

Yazdanpanah Y, Vray M, Meynard J, Losina E, Weinstein MC, Morand-Joubert L, Goldie SJ, Hsu HE, Walensky RP, Dalban C, Sax PE, Girard PM, Freedberg KA.

HIV Med. 2007 Oct;8(7):439-50.PMID: 17760736 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of enfuvirtide in treatment-experienced patients with advanced HIV disease.

Sax PE, Losina E, Weinstein MC, Paltiel AD, Goldie SJ, Muccio TM, Kimmel AD, Zhang H, Freedberg KA, Walensky RP.

J Acquir Immune Defic Syndr. 2005 May 1;39(1):69-77.PMID: 15851916 [PubMed - indexed for MEDLINE]Related articles

Cost effectiveness analysis of routine use of genotypic antiretroviral resistance testing after failure of antiretroviral treatment for HIV.

Corzillius M, Mühlberger N, Sroczynski G, Jaeger H, Wasem J, Siebert U.

Antivir Ther. 2004 Feb;9(1):27-36.PMID: 15040534 [PubMed - indexed for MEDLINE]Related articles

Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.

Paltiel AD, Walensky RP, Schackman BR, Seage GR 3rd, Mercincavage LM, Weinstein MC, Freedberg KA.

Ann Intern Med. 2006 Dec 5;145(11):797-806.PMID: 17146064 [PubMed - indexed for MEDLINE]Related articlesFree article

Expanded screening for HIV in the United States--an analysis of cost-effectiveness.

Paltiel AD, Weinstein MC, Kimmel AD, Seage GR 3rd, Losina E, Zhang H, Freedberg KA, Walensky RP.

N Engl J Med. 2005 Feb 10;352(6):586-95.PMID: 15703423 [PubMed - indexed for MEDLINE]Related articlesFree article

When to start antiretroviral therapy in resource-limited settings.

Walensky RP, Wolf LL, Wood R, Fofana MO, Freedberg KA, Martinson NA, Paltiel AD, Anglaret X, Weinstein MC, Losina E; CEPAC (Cost-Effectiveness of Preventing AIDS Complications)-International Investigators.

Ann Intern Med. 2009 Aug 4;151(3):157-66. Epub 2009 Jul 20.PMID: 19620143 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire.

Goldie SJ, Yazdanpanah Y, Losina E, Weinstein MC, Anglaret X, Walensky RP, Hsu HE, Kimmel A, Holmes C, Kaplan JE, Freedberg KA.

N Engl J Med. 2006 Sep 14;355(11):1141-53.PMID: 16971720 [PubMed - indexed for MEDLINE]Related articlesFree article

The cost-effectiveness of preventing AIDS-related opportunistic infections.

Freedberg KA, Scharfstein JA, Seage GR 3rd, Losina E, Weinstein MC, Craven DE, Paltiel AD.

JAMA. 1998 Jan 14;279(2):130-6. Erratum in: JAMA 1999 Jun 2;281(21):1989. PMID: 9440663 [PubMed - indexed for MEDLINE]Related articlesFree article

Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection.

Goldie SJ, Paltiel AD, Weinstein MC, Losina E, Seage GR 3rd, Kimmel AD, Walensky RP, Sax PE, Freedberg KA.

Am J Med. 2003 Dec 1;115(8):632-41.PMID: 14656616 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of genotypic antiretroviral resistance testing in HIV-infected patients with treatment failure.

Sendi P, Günthard HF, Simcock M, Ledergerber B, Schüpbach J, Battegay M; Swiss HIV Cohort Study.

PLoS One. 2007 Jan 24;2(1):e173.PMID: 17245449 [PubMed]Related articlesFree article

The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV.

Schackman BR, Scott CA, Walensky RP, Losina E, Freedberg KA, Sax PE.

AIDS. 2008 Oct 1;22(15):2025-33.PMID: 18784465 [PubMed - indexed for MEDLINE]Related articlesFree article

State AIDS Drug Assistance Programs: equity and efficiency in an era of rapidly changing treatment standards.

Johri M, David Paltiel A, Goldie SJ, Freedberg KA.

Med Care. 2002 May;40(5):429-41.PMID: 11961477 [PubMed - indexed for MEDLINE]Related articles

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Shepherd J, Jones J, Takeda A, Davidson P, Price A.

Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.PMID: 16904047 [PubMed - indexed for MEDLINE]Related articlesFree article

When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study.

Badri M, Cleary S, Maartens G, Pitt J, Bekker LG, Orrell C, Wood R.

Antivir Ther. 2006;11(1):63-72.PMID: 16518961 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of earlier initiation of antiretroviral therapy for uninsured HIV-infected adults.

Schackman BR, Goldie SJ, Weinstein MC, Losina E, Zhang H, Freedberg KA.

Am J Public Health. 2001 Sep;91(9):1456-63.PMID: 11527782 [PubMed - indexed for MEDLINE]Related articlesFree article